Skip to main content
. 2021 May 12;40(23):3929–3941. doi: 10.1038/s41388-021-01798-2

Fig. 3. ERK5 silencing suppresses breast cancer cell invasion.

Fig. 3

A, B Immunoblot analysis confirmed that shERK5(UTR) and shERK5(CDS) effectively downregulated ERK5 expression in MDA-MB-231 cells. Ectopic expression of ERK5 [+ F-ERK5(WT)] at a level similar to that of the endogenous protein was achieved by incubating shERK5(UTR)-expressing cells carrying an inducible F-ERK5(WT) construct with 10 ng/ml doxycycline (+) for 24 h. C ERK5 knockdown suppressed MDA-MB-231 cell invasion in FBS-free medium through Matrigel. The bar graph indicates the mean ± SD (N = 3). Representative pictures of the filters are shown. Scale bar: 200 μm. D Quantitative time course analysis of MDA-MB-231 cell adhesion on Matrigel by IncuCyte® live-cell imaging system. Representative pictures of cells taken 4 h after seeding in Matrigel-coated plates are shown. The data correspond to the mean ± SD (N = 3). E Lysates were obtained from cells cultured in FBS-free Matrigel-coated plates for 12 h and analyzed by immunoblot. The images are representative of three biological repeats. F Alternatively, transcript levels were measured by quantitative real-time PCR. Results are presented as fold change ± SD. The graph is representative of three independent biological repeats performed in duplicate.